News

2024

Nov. 26. 2024News

＜Blog 2＞Key considerations for unlocking Japan’s full cell & gene therapy and regenerative medicine potential
Nov. 15. 2024News

＜Blog 1＞Japan: A Unique Opportunity for Regenerative Medicine and Cell & Gene Therapy
Oct. 31. 2024News Release

Teijin and Hilleman Laboratories to Expand Business in AsiaPacific via Strategic Partnership to Promote CDMO Services in Cell and Gene Therapy
Apr. 26. 2024Event

～ Exhibition Schedule ～
Feb. 14. 2024News

Kashiwa-no-ha facility starts operation (News: Japanese only)

2023

Nov. 09. 2023News

TEIJIN REGENT official site is now available
Apr. 21. 2023News Release

Teijin, J-TEC and Resilience Form Business Alliance to Spur Development of New Regenerative Medicine Technologies
Mar. 28. 2023News Release

Teijin, Mediridge and TFBS Bioscience to Supply Raw Materials for Regenerative Medicine Development and Manufacture

2022

Sep. 27. 2022News Release

Teijin, J-TEC, Mitsui Fudosan and NCC to Establish Regenerative Medicine Platform